Trial · NCT03354598
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Sulopenem-etzadroxil/Probenecid | 835 | |
| Overall Study | STARTED | Ciprofloxacin | 836 | |
| Overall Study | Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants | Sulopenem-etzadroxil/Probenecid | 147 | |
| Overall Study | Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants | Ciprofloxacin | 139 | |
| Overall Study | Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants | Sulopenem-etzadroxil/Probenecid | 370 | |
| Overall Study | Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants | Ciprofloxacin | 415 | |
| Overall Study | Microbiologic Modified Intent to Treat (Micro-MITT) Participants | Sulopenem-etzadroxil/Probenecid | 517 | |
| Overall Study | Microbiologic Modified Intent to Treat (Micro-MITT) Participants | Ciprofloxacin | 554 | |
| Overall Study | Modified Intent to Treat (MITT) Participants | Sulopenem-etzadroxil/Probenecid | 785 | |
| Overall Study | Modified Intent to Treat (MITT) Participants | Ciprofloxacin | 794 | |
| Overall Study | Intent to Treat (ITT) Participants | Sulopenem-etzadroxil/Probenecid | 787 | |
| Overall Study | Intent to Treat (ITT) Participants | Ciprofloxacin | 803 | |
| Overall Study | Safety Participants | Sulopenem-etzadroxil/Probenecid | 833 | |
| Overall Study | Safety Participants | Ciprofloxacin | 827 | |
| Overall Study | COMPLETED | Sulopenem-etzadroxil/Probenecid | 755 | |
| Overall Study | COMPLETED | Ciprofloxacin | 761 | |
| Overall Study | NOT COMPLETED | Sulopenem-etzadroxil/Probenecid | 80 | |
| Overall Study | NOT COMPLETED | Ciprofloxacin | 75 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03354598/flow